Careers Form

" " indicates required fields

First name*

Last name*

Email*

Cell Phone*

LinkedIn profile*

Position*

Attach resume*

Max. file size: 256 MB.

Attach Cover letter

Max. file size: 256 MB.

Untitled

I would like to receive updates from C2A Security. I can unsubscribe at any time.

Using your personal data

I consent to the use of my personal information.

We're committed to protect your privacy. C2A Security uses the information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy .

Office Administrator

SBOM

FDA’s Postmarket Cybersecurity Guidance Is Due for an Update.

October 26, 2026

What Changes When Your Devices Are Already in the Field By Ken Zalevsky, VP and GM, C2A Security A revision would likely do more than

From Vulnerability Disclosure to Product Resilience: What the New International CVD Guidance Means for Manufacturers

July 16, 2026

C2A Security · July 2026 · 10 min read Executive Summary Cybersecurity is no longer measured solely by an organization’s ability to prevent vulnerabilities. Increasingly, regulators, customers, and

Can an Indirect Vulnerability Still Be High Risk?

January 22, 2026

CVE-2026-20045 does not directly affect most devices and products, but its potential impact depends entirely on how affected systems connect to them. CISA added CVE-2026-20045

From SBOMs to Defensible Decisions: Risk Based Prioritization in Medical Devices

January 13, 2026

Medical device manufacturers are no longer struggling to find vulnerabilities. They are struggling to decide which ones matter. As SBOM adoption has expanded, security and